Study Assessing Evaluation of the Interest of Serum S100B Protein Determination in the Management of Pediatric Mild Traumatic Brain Injury

NACompletedINTERVENTIONAL
Enrollment

2,209

Participants

Timeline

Start Date

November 2, 2016

Primary Completion Date

December 8, 2021

Study Completion Date

May 31, 2022

Conditions
Craniocerebral TraumaPediatrics
Interventions
PROCEDURE

usual care

PROCEDURE

S100B

Trial Locations (11)

13385

Assistance Publique des Hôpitaux de Marseille, Marseille

30900

Nimes Teaching Hospital, Nîmes

34090

Montpellier Teaching hopsital, Montpellier

42055

Saint-Etienne Teaching Hospital, Saint-Etienne

44036

Nantes Teaching Hospital, Nantes

51092

Reims Teaching Hospital, Reims

63003

CHU Clermont-Ferrand, Clermont-Ferrand

69677

Hospices Civils de LYON, Bron

87042

Limoges Teaching hospital, Limoges

06200

Nice Teaching Hospital, Nice

03200

Vichy Hospital Center, Vichy

All Listed Sponsors
lead

University Hospital, Clermont-Ferrand

OTHER

NCT02819778 - Study Assessing Evaluation of the Interest of Serum S100B Protein Determination in the Management of Pediatric Mild Traumatic Brain Injury | Biotech Hunter | Biotech Hunter